FOR IMMEDIATE RELEASE
Medidata Rave’s Ease of Deployment, Reliable Reporting Features and User-FriendlyTraining Tools Help Enable Leading CRO to Grow Global Client Base
NEW YORK, NY and RALEIGH, NC – Dec. 5, 2007 – Medidata Solutions, a global provider
of electronic clinical data capture (EDC), management and reporting solutions, and INC Research, a therapeutically-focused contract research organization (CRO) with a trusted process
for delivering reliable results, today announced their one-year ASPire to Win™ partnership milestone. In addition to INC Research’s experience offering eClinical solutions to its customers, keys to the success of this partnership include Medidata Rave’s fast and easy deployment capabilities, robust reporting tools and ability to handle any size global study.
Since November 2006, INC Research has implemented Medidata Rave® in 23 studies for 14
sponsors, across Phases I–IV and in a range of categories including CNS, pediatrics, oncology
and infectious disease. Medidata Rave has been deployed to manage trials of all sizes, from three
to 1,000 participants, and in global locations including Asia, Europe and South America. The
partnership has also yielded 15 Rave-certified study builders within INC Research’s clinical
programming and data management team in the U.S. and Europe. With these certifications, INC
Research can independently build and maintain studies in Rave and easily deploy Rave at the site
level.
Medidata Rave plays an integral role in INC Research’s Trusted Process™, which is its fourphased
approach to proactively lead customers through their drug and device development
programs with repeatable and measurable methodology. Rave helps ensure predictably
dependable outcomes and actionable results by increasing efficiency, decreasing time to trial
completion and maintaining clean data in the system at all times.
“With Rave as part of our Trusted Process, we are able to launch Rave-enabled studies quickly
and efficiently and provide our customers with a modern, flexible and single system for EDC and
CDMS,” said Alistair Macdonald, senior vice president of data services for INC Research. “In
addition to easy deployment, Medidata Rave can run very complicated studies faster than any
other system available today. Moreover, sites are clearly very comfortable working with the
Medidata Rave platform, and data managers benefit from access to data in real time with Rave’s
built-in reporting tools, providing insight throughout trials.”
In addition to Rave, INC Research has also been impressed with Medidata’s services and support
teams.
“Medidata’s work ethic aligns with ours—through open communication, rapid response to our
questions, and focus on customer care and management. We appreciate that Medidata
continually strives to deliver on time and exceed our expectations. We look forward to the next
phase of our relationship, which includes influencing product development based on market
trends,” said Macdonald.
“INC Research is an industry leader in its approach to EDC, and the clear investment in Rave
knowledge transfer across its clinical and data services organizations will help streamline clinical
processes for customers worldwide,” said Tarek Sherif, CEO of Medidata Solutions. “We look
forward to continuing our relationship into 2008 and beyond.”
About INC Research
INC Research is a therapeutically-focused contract research organization with an unrivaled reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric trials. The company’s Trusted Process™ methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina, and now in 24 locations in 32 countries worldwide. For more information please visit http://www.incresearch.com.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology, medical device and research organizations maximize the value of their clinical research investments. Innovative process design, technology and services streamline clinical trials by providing early visibility to reliable clinical data—the lifeblood of every research organization. Working with companies and institutions both large and small, Medidata Solutions helps clinical researchers safely accelerate the process of bringing life-enhancing treatments to market—on six continents and in more than 80 countries. Medidata Solutions brings significant value to its broad client base with deep clinical experience and expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. For more information, please visit www.mdsol.com.
Contact:
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com
Kelly Foster, INC Research
619-224-1261
kellyefoster@earthlink.net